These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27671724)

  • 1. Pathway Based Toxicology and Fit-for-Purpose Assays.
    Clewell RA; McMullen PD; Adeleye Y; Carmichael PL; Andersen ME
    Adv Exp Med Biol; 2016; 856():205-230. PubMed ID: 27671724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of fit-for-purpose assays within tiered testing approaches: A case study evaluating prioritized estrogen-active compounds in an in vitro human uterotrophic assay.
    Beames T; Moreau M; Roberts LA; Mansouri K; Haider S; Smeltz M; Nicolas CI; Doheny D; Phillips MB; Yoon M; Becker RA; McMullen PD; Andersen ME; Clewell RA; Hartman JK
    Toxicol Appl Pharmacol; 2020 Jan; 387():114774. PubMed ID: 31783037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating opportunities for advancing the use of alternative methods in risk assessment through the development of fit-for-purpose in vitro assays.
    McMullen PD; Andersen ME; Cholewa B; Clewell HJ; Dunnick KM; Hartman JK; Mansouri K; Minto MS; Nicolas CI; Phillips MB; Slattery S; Yoon M; Clewell RA
    Toxicol In Vitro; 2018 Apr; 48():310-317. PubMed ID: 29391263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Alternative In Vitro Methods to Animal Testing: Concepts, Challenges, Processes and Tools.
    Griesinger C; Desprez B; Coecke S; Casey W; Zuang V
    Adv Exp Med Biol; 2016; 856():65-132. PubMed ID: 27671720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose metric considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations.
    Groothuis FA; Heringa MB; Nicol B; Hermens JL; Blaauboer BJ; Kramer NI
    Toxicology; 2015 Jun; 332():30-40. PubMed ID: 23978460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral toxicology in the 21st century: challenges and opportunities for behavioral scientists. Summary of a symposium presented at the annual meeting of the neurobehavioral teratology society, June, 2009.
    Bushnell PJ; Kavlock RJ; Crofton KM; Weiss B; Rice DC
    Neurotoxicol Teratol; 2010; 32(3):313-28. PubMed ID: 20171276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative in vitro-to-in vivo extrapolation in a high-throughput environment.
    Wetmore BA
    Toxicology; 2015 Jun; 332():94-101. PubMed ID: 24907440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity testing in the 21 century: defining new risk assessment approaches based on perturbation of intracellular toxicity pathways.
    Bhattacharya S; Zhang Q; Carmichael PL; Boekelheide K; Andersen ME
    PLoS One; 2011; 6(6):e20887. PubMed ID: 21701582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaining acceptance for the use of in vitro toxicity assays and QIVIVE in regulatory risk assessment.
    Meek ME; Lipscomb JC
    Toxicology; 2015 Jun; 332():112-23. PubMed ID: 25598226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Developmental Toxicology Screens: A Report on the Progress of the Methodology and Future Applications.
    Zhang C; Ball J; Panzica-Kelly J; Augustine-Rauch K
    Chem Res Toxicol; 2016 Apr; 29(4):534-44. PubMed ID: 26766213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity testing in the 21st century beyond environmental chemicals.
    Rovida C; Asakura S; Daneshian M; Hofman-Huether H; Leist M; Meunier L; Reif D; Rossi A; Schmutz M; Valentin JP; Zurlo J; Hartung T
    ALTEX; 2015; 32(3):171-81. PubMed ID: 26168280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicology in the 21st century--working our way towards a visionary reality.
    Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
    Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing context appropriate toxicity testing approaches using new alternative methods (NAMs).
    Andersen ME; McMullen PD; Phillips MB; Yoon M; Pendse SN; Clewell HJ; Hartman JK; Moreau M; Becker RA; Clewell RA
    ALTEX; 2019; 36(4):523-534. PubMed ID: 31664457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of new technologies to characterization and prediction of adverse effects.
    Rouquié D; Heneweer M; Botham J; Ketelslegers H; Markell L; Pfister T; Steiling W; Strauss V; Hennes C
    Crit Rev Toxicol; 2015 Feb; 45(2):172-83. PubMed ID: 25615431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The US Federal Tox21 Program: A strategic and operational plan for continued leadership.
    Thomas RS; Paules RS; Simeonov A; Fitzpatrick SC; Crofton KM; Casey WM; Mendrick DL
    ALTEX; 2018; 35(2):163-168. PubMed ID: 29529324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative test methods in inhalation toxicology: challenges and opportunities.
    Costa DL
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotransformation in vitro: An essential consideration in the quantitative in vitro-to-in vivo extrapolation (QIVIVE) of toxicity data.
    Wilk-Zasadna I; Bernasconi C; Pelkonen O; Coecke S
    Toxicology; 2015 Jun; 332():8-19. PubMed ID: 25456264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.